Aldeyra Therapeutics Inc (ALDX)
4.19
+0.25
(+6.35%)
USD |
NASDAQ |
May 01, 16:00
4.01
-0.18
(-4.30%)
After-Hours: 20:00
Aldeyra Therapeutics Research and Development Expense (Quarterly): 4.298M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.298M |
| September 30, 2023 | 6.962M |
| June 30, 2023 | 6.963M |
| March 31, 2023 | 11.24M |
| December 31, 2022 | 8.962M |
| September 30, 2022 | 11.54M |
| June 30, 2022 | 14.57M |
| March 31, 2022 | 12.23M |
| December 31, 2021 | 12.84M |
| September 30, 2021 | 12.89M |
| June 30, 2021 | 11.47M |
| March 31, 2021 | 7.726M |
| December 31, 2020 | 7.028M |
| September 30, 2020 | 6.134M |
| June 30, 2020 | 4.886M |
| March 31, 2020 | 6.634M |
| December 31, 2019 | 9.614M |
| September 30, 2019 | 16.22M |
| June 30, 2019 | 10.66M |
| March 31, 2019 | 7.849M |
| December 31, 2018 | 8.549M |
| September 30, 2018 | 7.881M |
| June 30, 2018 | 6.793M |
| Date | Value |
|---|---|
| March 31, 2018 | 6.600M |
| December 31, 2017 | 5.545M |
| September 30, 2017 | 3.539M |
| June 30, 2017 | 3.849M |
| March 31, 2017 | 3.369M |
| December 31, 2016 | 3.447M |
| September 30, 2016 | 3.380M |
| June 30, 2016 | 2.834M |
| March 31, 2016 | 3.512M |
| December 31, 2015 | 3.112M |
| September 30, 2015 | 2.076M |
| June 30, 2015 | 1.249M |
| March 31, 2015 | 1.136M |
| December 31, 2014 | 1.404M |
| September 30, 2014 | 1.196M |
| June 30, 2014 | 0.6639M |
| March 31, 2014 | 0.4443M |
| December 31, 2013 | 0.4004M |
| September 30, 2013 | 0.666M |
| June 30, 2013 | 0.3251M |
| March 31, 2013 | 0.1502M |
| December 31, 2012 | 0.0962M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
4.298M
Minimum
Dec 2023
16.22M
Maximum
Sep 2019
9.626M
Average
9.614M
Median
Dec 2019
Research and Development Expense (Quarterly) Benchmarks
| AbbVie Inc | 1.939B |
| United Therapeutics Corp | 151.40M |
| Heron Therapeutics Inc | 10.95M |
| Esperion Therapeutics Inc | 17.74M |
| FibroGen Inc | 51.70M |